Children’s National Medical Center

Children’s National Medical Center

111 Michigan Ave NW

Washington, DC 20010

United States

Preliminary Content Validation Steps for the Pediatric Oncology Patient Self-Report CTCAE

Pam Hind The National Cancer Institute's Common Terminology Criteria for Adverse Events (CTCAE, version 4) is the standard lexicon for grading adverse events (AEs) experienced by pediatric cancer patients in oncology trials. The current standard in clinical trials is that all AEs are graded and reported by clinicians.

Immune Stimulatory Antigen Loaded Particles (ISAPS) for the Treatment of Solid Childhood Tumors

Neuroblastoma, General Pediatric Cancer

Current methods for treating tumors include surgery, chemo-therapy and radiation therapy. Immune therapy is a fourth dimension to cancer therapy that has great potential, but this potential is as yet unmet. We propose that a powerful immune response can be generated against a tumor by targeting specific cells of the immune system. These immune cells are involved in the immune response to fight "foreign bodies". We have evidence that specialized receptors and cells can be stimulated in the patient to shape the ideal immune response against a tumor.

Alex's Lemonade Stand Foundation for Childhood Cancer